Certified by Founder Lodge
Nuclera
United Kingdom - Cambridge, Cambridgeshire
START UP
1 Disclosed Funding Rounds $75,000,000
0 Participating Investments
-
Founded date
2013
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
At Nuclera, our mission is to better human health by making proteins accessible. We believe that providing rapid access to high-quality, soluble, active proteins at the benchtop will allow r
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 17 ,2024 | Unknown | $75,000,000 |
British Patient Capital
Cambridge Innovation Capital
Patient Square Capital
Elevage Medical Technologies
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Poetiq | $45,800,000 | (Feb 3, 2026)
1Buy.AI | $3,900,000 | (Feb 3, 2026)
Principle | $2,000,000 | (Feb 3, 2026)
Prenosis | $20,000,000 | (Feb 3, 2026)
PranaX | $17,000,000 | (Feb 3, 2026)
